Skip to main content

5 articles related to "Fc Effector Function"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 10 Sep 2021

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function

in Vaccines and Molecular Therapeutics

Simone I. Richardson
Frances Ayres
Nelia P. Manamela
Brent Oosthuysen
Zanele Makhado
Bronwen E. Lambson
Lynn Morris
Penny L. Moore

Frontiers in Immunology

doi 10.3389/fimmu.2021.733958

7,657 views
28 citations

Original Research

Published on 09 Apr 2024

Factor VIII moiety of recombinant Factor VIII Fc fusion protein impacts Fc effector function and CD16+ NK cell activation

in Immunological Tolerance and Regulation

H.A. Daniel Lagassé
Jiayi Ou
Zuben E. Sauna
Basil Golding

Frontiers in Immunology

doi 10.3389/fimmu.2024.1341013

3,745 views
1 citation

Original Research

Published on 06 Jan 2022

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

in Viral Immunology

William D. Tolbert
Dung N. Nguyen
Marina Tuyishime
Andrew R. Crowley
Yaozong Chen
Shalini Jha
Derrick Goodman
Valerie Bekker
Sarah V. Mudrak
Anthony L. DeVico

Frontiers in Immunology

doi 10.3389/fimmu.2021.787603

5,364 views
1 citation

Original Research

Published on 11 Jul 2023

Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity

in Molecular Innate Immunity

Olena Zaitseva
Annett Hoffmann
Margaretha Löst
Mohamed A. Anany
Tengyu Zhang
Kirstin Kucka
Armin Wiegering
Christoph Otto
Harald Wajant

Frontiers in Immunology

doi 10.3389/fimmu.2023.1194610

4,169 views
3 citations

Original Research

Published on 22 Feb 2022

An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models

in Cancer Immunity and Immunotherapy

Xin Chen
Liu Xue
Xiao Ding
Jing Zhang
Lei Jiang
Sha Liu
Hongjia Hou
Bin Jiang
Liang Cheng
Qing Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2022.828319

17,017 views
53 citations